Matthew Hewitt, PhD, currently serves as the Executive Director, Scientific Services, Cell & Gene Therapy (CGT) at Charles River Laboratories (CRL). In this role, Matt leads one of Charles River’s CGT CDMO sites in helping partners move assets to clinic and commercial. Matt is also responsible for leading conversations on CRL’s cell and gene therapy strategic approach
Also Speaking
Xavier De Mollerat Du Jeu
Senior Director of Research and Development • Thermo Fisher Scientific Inc
9 November 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023